Severe interstitial nephritis in a patient with renal amyloidosis and exacerbation of Crohn's disease

Clinical Nephrology

Volumn 53, Issue 2, 2000, Pages 147-151

  Tovbin, D ^a,b   Kachko, L ^a   Hilzenrat, N ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Amyloidosis; Crohn's disease; Interstitial nephritis; Ischemia; Proteinuria

Indexed keywords

STEROID;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY AMYLOIDOSIS; KIDNEY FUNCTION; MALE; NEPHROTIC SYNDROME; PLASMA VOLUME; PROTEINURIA; STEROID THERAPY;

AMYLOIDOSIS; BIOPSY; CROHN DISEASE; GLUCOCORTICOIDS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; NEPHROTIC SYNDROME; PREDNISONE;

EID: 0033976012     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Alfrey AC 1994 Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 23: 183-187
2. Bertani T, Cuttilo F, Zojn C, Broggini M, Remmuzi G 1986 Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30; 488-496
3. Borras M, Lopez D, Olive A, Teixido J 1991 Rapidly progressive kidney failure and amyloidosis AA. Med Clin (Barc) 97: 557
4. Cerdan FJ, Diez M, Perez de Oteiza C, Martinez S, Hernandez Merio F, Balbrea JL 1991 Renal amyloidosis in a case of Crohn disease with colonic and rectal involvement. Rev Esp Enferm Dig 80: 123-126
5. Damico G, Ferrario F, Rastaldi MP 1995 Tubulointerstitial damage in glomerular disease: its role in progression of renal damage. Am J Kidney Dis 26: 124-132
6. Damico G 1998 Tubulo-interstitial damage in glomerular disease: its role in the progression of the renal damage. Nephrol Dial Transplant 13 (Suppl 1): 80-85
7. Eddy AA 1994 Experimental insights into the tubulointerstitial disease accompanying primary glomerular lessions. J Am Soc Nephrol 5: 1273-1287
8. Efstratiadis G, Mainas A, Leontsini M 1996 Renal amyloidosis complicating Crohn's disease; case report and review of the literature. J Clin Gastroenterol 22: 308-310
9. Ehrenreich H, Andreson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl JH, Fauci AS 1990 Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 172: 1741-1748
10. Fine LG, Norman JT, Ong A 1995 Cell-cell cross talk in the pathogcnesis of renal interstitial fibrosis. Kidney Int 47: 48-50
11. Hanggono T, Rao GS 1992 Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem Biophys Res Commun 189: 994-1000
12. Keen-Folts D, Sadow JL, Schreiner GF 1994 Tubular catabolism of albumin is associated with the release of anti-inflammatory lipid. Kidney Int 45: 1697-1709
13. Kleinman JG, Worcester FM, Hushensky AM, Sheridan AM, Bonventre JV, Brown D 1995 Upregulation of osteopontin expression by ischemia in rat kidney. Ann NY Acad Sci 760: 321-323
14. Kohan DE 1991 Endothelin synthesis by rabbit renal tubule cells. Am J Physiol 261: 221-226
15. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D 1979 Renal filtration, transport and metabolism of low-molecular weight proteins: a review. Kidney Int 16: 252-270
16. Nath KA, Hostetter MK, Hostetter TH 1985 Pathophysiology of chronic tubulo-interstitial disease in rats: interaction of dietary acid load, ammonia, and complement component C3. J Clin Invest 76: 667-75
17. Nath KA, Hostetter MK, Hosteller TH 1989 Ammonia complement interaction in the pathogenesis of progressive renal failure. Kidney Int 36 (27 Suppl): S52-54
18. Olbricht CJ, Cannon JK, Garg LC, Tisher C 1986 Activities of cathepsin B and L in isolated nephron segments from proteinuric and normo-proteinuric rats. Am J Physiol 250: 1055-1062
19. Palmer B 1997. The renal tubule in progression of chronic renal failure. J Invest Med 45: 346-360
20. Rose BD and Black RM 1996 Acute drug-induced interstitial nephritis. In: Rose BD, Black RM (eds) Clinical Problems in Nephrology. Little, Brown and Company, Boston, pp 246-252
21. Rustom R, Jackson MJ, Critchley M. Bone JM 1992 Tubular metabolism of aprotinin and urinary ammonia. Effects of proteinuria. Miner Electrolyte Metab 18: 108-112
22. Remuzzi G, Ruggenenti P, Benigni A 1997 Understanding the nature of renal disease progression. Kidney Int 51: 2-15
23. Shackelton C 1990 Effect of recovery from ischemic injury on class II MHC antigen presentation. Transplantation 49: 641-644
24. Sanchez Lombrana JL, Trivino L, Linares A, Navascues CS, Perez R, Rodriguez M, Rodrigo L 1991 Crohn's disease and amyloidosis. An association to be considered. Rev Esp Enferm Dig 80: 337-341
25. Smith JD, Hayslett JP 1992 Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis 19: 201-213
26. Sponsel HT, Alfrey AC, Hammond WS, Durr JA, Ray C, Andersen RJ 1996 Effect of iron on renal tubular epithelial cells. Kidney Int 50: 436-444
27. Trivino A, Sanchez Lombrana JL Linares A, Perez R, Herrero Zapatero A, Rodrigo L 1992 Ulcerative colitis and amyloidosis. Presentation of a case and review of the literature. Rev Esp Enferm Dig 82: 117-120
28. Wehrmann M, Bohle A, Eissele R, Von Gise H, Makkensen-Haen S 1992 Importance of glomerular and tubulointerstitial changes for long-term prognosis of AA-and Al-amyloidosis. An analysis of 225 cases. Pathology 13: 4-12
29. Zager RA, Teubner EJ, Adler S 1987 Low molecular weight proteinuria exacerbates experimental ischemic injury. Lab Invest 56: 180-188